Heligenics is a biotechnology company based in Las Vegas that focuses on genetic diagnostics and drug discovery. The company utilizes its proprietary GigaAssay platform to produce and test the functional impact of all genetic variants for a given gene in live human cells. The company uses the platform for various applications, including improved diagnostics, companion diagnostics, precision clinical trials, and the development of novel biologics and biobetters.

Heligenics has raised $1.18 million in seed funding.[source][source]

“`